X - закрыть окно

Литература
1. Rice-Evans C.A. Parker L. (Eds. ) Flavonoids in Health and Diseases. —Marcel Dekker, New York, 1997.
2. Чекман І.С. Флавоноїди: клініко-фармакологічний аспект // Фітотерапія в Україні. —2000. —№2. —С. 3—5.
3. Middleton E., Kandaswami C., Theoharides T. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart diseases and cancer // Pharmacol. Rev. -2000. —Vol. 52. —P. 673—751.
4. Bravo L. Poliphenols, chemistry, dietary, sources, metabolism and nutritional significance // Nutr. Rev. —1998. —Vol. 56. —P. 317—333.
5. Ялкут С. М., Циприян В. И. Профилактическое питание в онкологии. Москва: Полиграф Тех Сервис, 2002. —C. 67.
6. Лікарські рослини: Енциклопедичний довідник / Відп. ред. А.М. Гродзинський. —К., 1989. —C. 115.
7. Nakayama T., Yamada M., Osawa T et al. Supression of active oxygen-induced cytotoxicity by flavonoids // Biochem. Pharmacol. —1993. —Vol. 45. —P. 265—267.
8. Contestabile A. Antioxidant strategies for neurodegenerative diseases // Expert Opin. Therapeutic Patentis. —2001. —Vol. 11. —P. 573—585.
9. Halliwell B., Gutteridge (Eds) Free Radicals in Biology and Medicine. —Clarendon Press, Oxford (Uk), 1985. —P. 167.
10. Halliwell B. Reactive oxygen species and the central nervous system // J. Neurochem. —1992. —Vol. 59. —P. 1609—1623.
11. Buttke T.M. Sadstrom P.P. Oxidative — stress as a mediator of apoptosis // Immunol. Todey. —1994. —Vol. 15. —P. 7—14.
12. Stoian J., Oros A., Moldovean E. Apoptosis and free radicals. // Biochem. And Biol. Med. —1996. —Vol. 59. —P. 93—98.
13. Morel I., Cillard P. and Cillard J. Flavonoid — metal interaction in biological systems. In: (Eds) C. Rice-Evans and L. Parcer. Marcel Dekker, New York, 1997. —P. 67—90.
14. Paladini A. C., Marder M. Viola H. et al. Flavonoids and the central nervous system: from forgotten factors to potent anxiolytic compounds // J. Pharm. Pharmacol. —1999. —Vol. 51. —P. 519—526.
15. Wang H., and Joseph J.A. Structure — activity relationships of quercetin in antagonizing hydrogen peroxide — induced calcium dysregulation in PC 12 cells // Free Radic. Biol. Med. —1999. —Vol. 27. —P. 683—694.
16. Shinya K., Kumigami T., Kim J. S. et al. Protective effect of catechin agains betaamyloid toxicity in hippocampal neurons and PC 12 cells // J. Neurochem. —1997. —Vol. 69. —P. 41—42.
17. Dore S., Bastianetto S., Kar S. et al. Protective and rescuing abilities of IGF-1 and some putative free radical scavengers against beta-amyloid toxicity in neurons // Ann. NY Acad. Sci. —1999. —Vol. 890. —P. 356—364.
18. Bastianetto S. Ramassamy C., Dore S. et al. The ginkgo biloba extract (Erb 761) protects hyppocampal neurons against cell death induced by beta-amyloid // Eur. J. Neurosci. —2000. —V. 12. —P. 1882—1890.
19. Ishige K., Schubert D., and Sagara Y. Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms // Free Radic. Biol. Med. —2001. —Vol. 30. —P. 433—446.
20. Medina J.H., Viola H., Wolfman C. et al. Neuroactive flavonoids: new ligands for the benzodiazepine receptor // Phytomedicine. —1998. —Vol. 5. —P. 235—243.
21. Dekermendjan K., Kahnuberg P., Witt M. R. et al. Structure activity relationship and molecular modeling analysis of flavonoids binding to the benzodiazepine site of the rat brain GABA receptor complex // J. Med. Chem. —1999. —Vol. 42. —P. 4343—4350.
22. Moro S., van Rhee A.M., Sanders L. et al. Flavonoid derivatives as adenosine receptor antagonists: a comparison of the hypothetical receptor binding site based on a comparative field analysis model // J. Med. Chem. —1998. —Vol. 41. —P. 46—52.
23. Suganuma M., Okabe S., Oniyama M. et al. Wide distribution of (H)-epigallocatechin gullate, a cancer preventive ten polyphenol, in mouse tissue // Carcinogenesis. —1998. —Vol. 19. —P. 1771—1776.
24. Tsai T.H., Chen Y.E. Determination of unbound hesperetin in rat blood and brain by microdialysis coupled fo microbore liquid chromatography // J. Food Drug. Anal. —2000. —Vol. 8. —P. 331—336.
25. Peng H.W., Cheng F.C. Huang Y.T. et al. Determination of naringenin and its glucuronide conjugate in rat plasma and brain tissue by hight-performance liquid chromatography // J. Chromatogr. —1998. —Vol. 714. —P. 369—374.
26. Schroder van der Elst J.P., Heide D., Rocos H., et al. Different tissue distribution, elimination and kinetics of thizoxine and conformatial analog, the synthetic flavonoid Emd 49209 in the rat // Endocrinology. —1997. —Vol. 138. —P. 79—84.
27. Schroder van der Elst J.P., Heide D., Rokos H. et al. Synthetic flavonoids cross the placenta in the rat and are found in the fetal brain // Am. J. Physiol. —1998. —Vol. 274. —P. 253—256.
28. Spencer J.P.E., Chowrimoto G., Choudhury R. et al. The small intestine can both absorb and glucuronidate luminal flavonoids // FEBS Lett. —1999. —Vol. 458. —P. 224—230.
29. Kuhule G., Spencer J.P., Schroeter H. et al. Epicatechin and catechin are O-methylated and glucuronidated in the small intestine // Biochem. Biophys. Res. Commun. —2000. —Vol. 227. —P. 507—512.
30. Rice-Evans C., Spencer J., Schroeter H. et al. Bioavailably of flavonoids and potential bioactive forms in vivo // Drug Metab. Drug. Interact. —2001. —Vol. 17. —P. 291—310.
31. CRC Handbook of Mammalian Metabolism of Plant Compounds / Scheline R. R. (Ed.): CRS Press, Boka Raton, 1991. —P. 59.
32. Shimoi K., Okada H., Furugori M. et al. Intestinal absorption of luteolin and luteolin-7-0-b-glucoside in rats and humans // FEBS Lett. —1998. —Vol. 438. —P. 220—224.
33. Okushio K., Suzuki M., Matsumoto N. at al. Identification of epicatechin metabolites and their metabolic fate in the rat // Drug. Metab. Dispos. —1999. —Vol. 27. —P. 309—316.
34. Harada M., Kan Y., Naoki H. et al. Identification of the major antioxidative metabolites in biological fluids of the rat with ingested (+)-catechin and (-)-epicatechin // Biosci. Biotech. Biochem. —1999. —Vol. 63. —P. 973—977.
35. Baba S., Osakabe N., Yasuda A. et al. Bioavailability of epicatechin upon intake of chocolate and cocoa in human volunteers // Free Radic. Res. —2000. —Vol. 33. —P. 635—641.
36. Rechner A.R., Spencer J.P., Kuhule G. et al. Novel biomarkers of the metabolism of caffeic acid derivatives in vivo // Free Radic. Biol. Med. —2001. —Vol. 30. —P. 1213-1222.
37. Wyllie A., Kerr J., Currie A. Cell Death: the significante of apoptosis // Int. Rev. Cytol. —1980. —Vol. 68. —P. 251—306.
38. Фильченков А.А., Абраменко И.В. Апоптоз в патогенезе заболеваний человека. —К.: ДНА, 2001. —120 c.
39. Самуилов В.Д., Олескин А.В., Лагунов Е.М. Программируемая клеточная смерть // Биохимия. —2000. — Т. 65, Вып. 8. —С. 1029—1046.
40. Nicholson D.W., Ali A., Thoraberry N.A. et al. Caspases: killer proteases // Nature. —1995. —Vol. 376. —P. 37—41.
41. Фильченков А.А., Стойка Р.С. Апоптоз и рак. —К.: МОРИОН, 1999. —76 c.
42. Залесский В.Н., Тимченко А.С., Фильченков А.А. Ультрафиолетовое излучение и апоптоз // Журн. АМН Украины. —2002. —T. 8, №2. —C. 250—268.
43. Залесский В.Н., Гавриленко Т.И., Фильченков А.А. Апоптоз при ишемии и реперфузии миокарда // Врач. дело. —2002. —№1. —С. 8—15.
44. Залесский В.Н., Фильченков А.А. Перспективы патогенетически обоснованного применения модуляторов апоптоза в качестве нейро-, кардио-, гепато- и нефроцитопротекторов // Совр. проблемы токсикологии. —2003. —№4. —C. 64—70.
45. Залесский В.Н., Великая Н.В. Механизмы цитотоксических эффектов активных молекул кислорода и развитие апоптоза // Совр. проблемы токсикологии. —2002. —№1. —С. 11—17.
46. Beck T., Lindholm D., Castren E., and Wree A. Brain-derived neurotrophic factors protects against cell damage in rat // J. Cereb. Blood Flow. Metab. —1994. —Vol. 14. —P. 689—692.
47. Chopp M., Li Y. Apoptosis in focal cerebral ischemia // Acta Neurochir. —1996. —Vol. 66. —P. 21—26.
48. Walton M., Connor P., Lawlor P. et al. Neuronal death and survival in two models of hypoxic-ischemic brain damage // Brain Res. Rev. —1999. —Vol. 29. —P. 137—168.
49. Iadecola C., Alexander M., Cerebral ischemia and inflammatory // Curr. Opin. Neurol. —2001. —Vol. 14. —P. 89—94.
50. Love S. Oxidative stress in brain ischemia // Brain Pathol. —1999. —Vol. 9. —P. 119—131.
51. Toku K., Tanaka H., Yano H. et al. Microglial cells prevent nitric oxide-induced neuronal apoptosis in vitro // J. Neurosci. Res. —1998. —Vol. 53. —P. 415—425.
52. Antonawich F.J., Krajewski S., Reed J.C. Bcl-xl/ Bux interaction after transient global ischemia // J. Cereb. Blood. Flow Metab. —1998. —Vol. 18. —P. 882—886.
53. Mc Gahan L., Hakim A.M. Hippocampal Myc and p 53 expression following transient global ischemia // Mol. Brain. Res. —1998. —Vol. 56. —P. 133—145.
54. Fortin A., Cregan S.P., Mc Laurin J.G. APAF 1 is a key transcriptional target for p53 in regulation of neuronal cell death // J. Cell. Biol. —2001. —Vol. 155. —P. 207—216.
55. Jin K., Graham S.H., Mao X. Fas (CD 95) may mediate delayed cell death in hippocampal CA 1 sector after global cerebral ischemia // J. Cereb. Blood. Flow Metab. —2001. —Vol. 21. —P. 1411—1421.
56. White J.R., Reynolds I.J. Mitochondrial depolarization in glutamate stimulated neurons: An early signal specific to excitotoxin exposure // J. Neurosci. —1996. —Vol. 16. —P. 5688—5697.
57. Asai A., Qin J., Narita Y. et al. High level calcineurin activity predisposes neuronal cells to apoptosis // J. Biol. Chem. —1999. —Vol. 274. —P. 3450—3458.
58. Cao G., Minami M., Pei W. et al. Intracellular Bax translocation after transient cerebral ischemia: implications for a role of the mitochondrial apoptosis signaling pathway in ischemic neuronal death // J. Cereb. Blood. Flow Metab. —2001. —Vol. 21. —P. 321-333.
59. Nutt L.K., Chandra J. Bax-mediated Ca mobilization promotes cytochrome c release during apoptosis // J. Biol. Chem. —2002. —Vol. 277. —P. 20301—20308.
60. Sugawara T., Noshita N., Leven A. et al Overexpression of copper/zinc superoxide dismutase in transgenic rats protects vulnerable neurons against ischemic damage by blocking the mitochondrial pathway of caspase activation // J. Neurosci. —2002. —Vol. 22. —P. 209-217.
61. Gross A., Yin X.M., Wang K. et al. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while Bcl-xl prevents this release but not tumor necrosis factor-R 1/Fas death // J. Biol. Chem. —1999. —Vol. 274. —P. 1156—1163.
62. Plesnila N., Zinkel S., Le D. A. et al. BID mediates neuronal cell death after oxygen/glucose deprivation and focal cerebral ischemia // Proc. Natl. Acad. Sci. USA. —2001. —Vol. 98. —P. 15318—15323.
63. Lin X.H., Kwon D., Schielke G.P. et al. Mice deficient in interleukin-1 converting enzyme are resistant to neonatal hypoxic-ischemic brain damage // J. Cereb. Blood. Metab. —1999. —Vol. 19. —P. 1099—1109.
64. Kang S.L., Wang S., Hara H. et al. Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathological condition // Cell. Biol. —2000. —Vol. 149. —P. 613—622.
65. Kuida K., Zheng T., Na S. et al. Decreased apoptosis in the brain and premature lethality in CPP 32-deficient mice // Nature. —1996. —Vol. 384. —P. 386—372.
66. Harrison D.S., Medhurst A B.S., Bond B.C. et al. The use of quantidative RT-PCR to measure m RNA expression in rat model of focal ischemia-caspase-3 as a case study // Mol. Brain res. —2000. —Vol. 75. —P. 143—149.
67. Springer J.E., Azbill R.D., Knapp P.E. Activation of the caspase-3 apoptotic cascade in cerebral injury // Nat. Med. —1999. —Vol. 5. —P. 943—946.
68. Henning R., Ryan C.A., Salvessen G.S. Reprieval from execultion: the molecular basis of caspase inhibition // TIBS. —2002. —Vol. 27. —P. 94—101.
69. Sakahira H., Ewary M., Nagata S. Cleavage of CAD inhibitor in CAD action and DNA degradation during apoptosis // Nature. —1998. —Vol. 391. —P. 96—99.
70. Wang X., Yue T.L. Barone F.C. et al. Concominant cortical expression of TNF-alpha and IL-1 beta m RNAs follows early response gene expression in transient // Mol. Chem. Neuropathol. —1994. —Vol. 23. —P. 103—114.
71. Chen C.C., Manning A.M. TNF-beta 1, IL-4 differentially endothelial cells // Cytokine. —1996. —Vol. 8 (1). —P. 158—165.
72. Issazadeh S., Lorentzen J.C., Mustafa M.I. et al. Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: persistent of m RNA expression of proinflammatory cytokines and absent expression // J. Neuroimmunol. —1996. —Vol. 69 (1—2). —P. 103—115.
73. Nakajima Y., Mori A., Maeda T. Morphological investigation of the neuroprotective effects of graded hypothermia after diverse periods of global cerebral ischemia in gerbils // Brain Res. —1997. —Vol. 765 (1). —P. 113—121.
74. Kang H., Shuman E.M. Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hyppocampus // Science. —1995. —Vol. 267. —P. 1658—1662.
75. Аммарин Н.П. Стукалов П.В. Нейрохимия. —М.: Изд-во Инс. биомед. химии РАМН, 1996. —286 с.
76. Залесский В.Н., Великая Н.В. Антиапоптические, проапоптические и антитоксические реакции молекул флавоноидов — растительных фенолов // Проблеми харчування. —2003. —№1. —С. 38—43.
77. Yuan J., and Yancuer B. Apoptosis in the nervous system // Nature. —2000. —Vol. 407. —P. 802—809.
78. Zhang Y., Dawson V.L., Dawson T.M. Oxidative stress and genetics factors in the pathogenesis of Parkinsonўs disease // Neurobiol. Dis. —2000. —Vol. 7. —P. 240—250.
79. Eisen A., Krieger C. Pathogenic mechanisms in sporadic amiotrophic lateral sclerosis // Can. J. Neurol. Sci. —1993. —Vol. 20. —P. 286—296.
80. Hertog M., Feskens E., Hollman P. et al. Dietary antioxidant flavonoids and the risk of coronary heart disease // Lancet. —1993. —Vol. 342. —P. 1007—1011.
81. Hirvonen T., Pietinen P., Virtanen M. et al. Intake of flavonols and flavonones and the risk of coronary heart disease in male smokers // Epidemiology. —2000. —Vol. 12. —P. 62—67.
82. Gramaglia A., Loi G., Mongioj V., Baronzio G. Increased survival in metastatic patients treated with stereotactic radiotherapy, omega three fatty acids and bioflavonoids // Anticancer Res. —1999. —Vol. 19. —P. 5583—5586.
83. Yule D.L., Rim E.T., Williams J.A. Tyrosine kinase inhibitors attenuate capacitive Ca influx in rat pancreatic acinar cells // Biochem. Biophys. Res. Commun. —1994. —Vol. 202. —P. 1697—1764.
84. Chan F.L., Choi H.K., Chen Z.Y. et. al. Induction of apoptosis in prostate cancer cell lines by a flavonoid, baicalin // Cancer Lett. —2000. —Vol. 160. —P. 219—228.
85. Wenzel H., Kuntz S., Brendel M. et al. Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells // Cancer Res. —2000. —Vol. 61. —P. 3823—3831.
86. Schroeter H., Williams R., Matin R. et al. Phenolic antioxidants attenuate neuronal cell death following up take of oxidized low-density lipoprotein // Free Radic. Biol. Med. —2000. —Vol. 29. —P. 1222—1233.
87. Spencer J.P., Schroeter H., Crossthwaithe A.J. et al. Contrasting influences of glucuronidation and O-methylation of epicatechin on hydrogen peroxide induced cell death in neurons and fibroblast // Free Radic. Biol. Med. —2001. —Vol. 31. —P. 1139—1146.
88. Bagchi D., Bagchi M., Stohs I. et al. Cellular protection with proanthocyanidins derived from grape seeds // Ann. N. Y. Acad. Sci. —2002. —Vol. 957. —P. 260—270.
89. Kong A., Yu R., Chen C. et al. Signal transduction events elicited by natural products, role of MAPK and caspase pathways in homeostatic response and induction of apoptosis // Arch. Pharm. Res. —2000. —Vol. 23. —P. 1—16.
90. Davis R.J. Signal transduction by the JNK Group of MAP kinases // Cell. —2000. —Vol. 109. —P. 239—252.
91. Mielke K., Herdegen T. JNK and p38 stress kinases-degenerative effectors of signal transduction-cascades in the nervous system // Prog. Neurobiol. —2000. —Vol. 61. —P. 45—60.
92. Schroeter H., Spencer J.P., Rice-Evans C. et al. Flavonoids protect neurons from oxidized low-density lipoprotein-induced apoptosis involving JNK, c-jun, and caspase-3 // Biochem. J. —2001. —Vol. 358. —P. 547—557.
93. Hong J., Ryu S., Kim H. et al. Neuroprotective effect of green tea extract in experimental ischemia-reperfusion brain injury // Brain Res. Bull. —2000. —Vol. 53. —P. 743—749.
94. Hong J., Ryu S., Kin H. et al. Protective effect of green tea extract on ischemia/reperfusion-induced brain injury in Mongolian gerbils // Brain Res. —2001. —Vol. 888. —P. 11—18.
95. Hellenbrand W., Boeing H., Robra B. et al. Diet and Parkinsonўs disease: a possible role for the past intake of specific nutrients // Neurol. —1996. —Vol. 47. —P. 644—650.
96. Lin A., Chyi B., Wu L. et al. The antioxidative property of green tea against iron-induced oxidative stress in rat brain // Chin. J. Physiol. —1998. —Vol. 41. —P. 189—194.
97. Inanami O., Watanabe Y., Synto B. et al. Oral administration of catechin protects against ischmia-reperfusion-induced neuronal death in the gerbil // Free Radic. Res. —1998. —Vol. 29. —P. 359—365.
98. Lee S., Suh S., and Kim S. Protective effects of green tea polyphenol (-) epigallocatechin gallate against hippocampal neuronal damage after transient global ischemia in gerbils // Neurosci. Lett. —2000. —Vol. 287. —P. 191—194.
99. Залесский В.Н., Великая Н.В. Механизмы апоптоза при заболеваниях печени // Совр. прол. токсикол. —2002. —№4. —С. 27—32.
100. Фильченков А.А., Залесский В.Н. Апоптоз кортикальных нейронов при развитии ишемических инсультов // Нейрофизиология. —2002. —Т. 34, №6. —С. 468—484.